On Tuesday, Halozyme Therapeutics Inc (NASDAQ: HALO) was 1.19% up from the session before settling in for the closing price of $48.03. A 52-week range
On Tuesday, Halozyme Therapeutics Inc (NASDAQ: HALO) opened at On Tuesday, remained unchanged from the last session, before settling in for the closing price of
On Tuesday, Halozyme Therapeutics Inc (NASDAQ: HALO) opened lower -0.23% from the last session, before settling in for the closing price of $48.59. Price fluctuations
Halozyme Therapeutics Inc (NASDAQ: HALO) on Friday, soared 7.22% from the previous trading day, before settling in for the closing price of $45.70. Within the
Halozyme Therapeutics Inc (NASDAQ: HALO) started the day on Wednesday, with a price increase of 2.12% at $45.76, before settling in for the price of
A new trading day began on Friday, with Halozyme Therapeutics Inc (NASDAQ: HALO) stock price down -15.40% from the previous day of trading, before settling
Halozyme Therapeutics Inc (NASDAQ: HALO) on Tuesday, plunged -2.42% from the previous trading day, before settling in for the closing price of $61.09. Within the
On Monday, Halozyme Therapeutics Inc (NASDAQ: HALO) opened higher 2.31% from the last session, before settling in for the closing price of $57.15. Price fluctuations
Halozyme Therapeutics Inc (NASDAQ: HALO) flaunted slowness of -0.04% at $50.57, before settling in for the price of $50.59 at the close. Taking a more
Halozyme Therapeutics Inc. (NASDAQ: HALO) started the day on Wednesday, with a price decrease of -1.45% at $50.80, before settling in for the price of
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
